Eric D Peterson Selected Research

Clopidogrel (Plavix)

12/2021	Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure.
1/2019	Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial.
1/2018	Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome) Study.
1/2018	Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry.
1/2018	The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
5/2017	Association of measured platelet reactivity with changes in P2Y12 receptor inhibitor therapy and outcomes after myocardial infarction: Insights into routine clinical practice from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study.
1/2017	Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study.
10/2016	Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
9/2016	Spotlight on unmet needs in stroke prevention: The PIONEER AF-PCI, NAVIGATE ESUS and GALILEO trials.
9/2016	Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric D Peterson Research Topics

Disease

145	Myocardial Infarction 01/2022 - 07/2003
124	Hemorrhage 01/2021 - 02/2005
123	Stroke (Strokes) 01/2022 - 03/2005
96	Atrial Fibrillation 09/2021 - 08/2008
83	Acute Coronary Syndrome 07/2021 - 11/2002
82	Heart Failure 01/2022 - 07/2004
80	ST Elevation Myocardial Infarction 03/2021 - 10/2004
58	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 11/2002
58	Ischemic Stroke 01/2022 - 02/2010
41	Coronary Artery Disease (Coronary Atherosclerosis) 10/2019 - 05/2004
30	Non-ST Elevated Myocardial Infarction 03/2021 - 05/2005
28	Unstable Angina 12/2019 - 06/2003
26	Hypertension (High Blood Pressure) 01/2022 - 10/2005
24	Diabetes Mellitus 01/2020 - 08/2002
22	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2015
21	Renal Insufficiency (Renal Failure) 12/2017 - 10/2002
16	Chronic Renal Insufficiency 09/2021 - 03/2006
15	Thrombosis (Thrombus) 11/2020 - 06/2006
13	Transient Ischemic Attack 08/2019 - 09/2009
12	Peripheral Arterial Disease 01/2019 - 12/2010
12	Cardiogenic Shock 01/2018 - 08/2003
11	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 06/2012
11	Infarction (Infarctions) 01/2018 - 09/2005
11	Infections 08/2013 - 08/2002
9	Shock 01/2019 - 11/2006
9	Vascular Diseases (Vascular Disease) 01/2019 - 03/2007
9	Left Ventricular Dysfunction 03/2011 - 10/2005
8	Coronary Disease (Coronary Heart Disease) 01/2022 - 09/2006
8	Embolism (Embolus) 01/2020 - 12/2015
7	Body Weight (Weight, Body) 01/2022 - 06/2009
7	Cerebral Hemorrhage 01/2021 - 05/2013
7	Hyperlipidemias (Hyperlipidemia) 01/2020 - 09/2006
7	Frailty 01/2019 - 07/2013
6	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020 - 09/2007
6	Aortic Valve Stenosis (Aortic Stenosis) 01/2020 - 09/2004
6	Pathologic Constriction (Stenosis) 12/2017 - 10/2006
6	Chest Pain (Chest Pains) 08/2014 - 07/2003
5	Obesity 01/2020 - 10/2002
5	Lung Diseases (Lung Disease) 01/2018 - 11/2006

Drug/Important Bio-Agent (IBA)

49	Warfarin (Coumadin)FDA LinkGeneric 10/2020 - 02/2008
45	AnticoagulantsIBA 01/2022 - 03/2012
35	Clopidogrel (Plavix)FDA Link 12/2021 - 04/2004
32	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 01/2008
30	LipidsIBA 07/2021 - 02/2005
29	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021 - 07/2005
26	Vitamin K FDA Link 01/2022 - 08/2014
23	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2021 - 07/2006
22	RivaroxabanIBA 01/2020 - 07/2015
21	Sitagliptin Phosphate (Januvia)FDA Link 01/2022 - 07/2015
18	Adenosine Diphosphate (ADP)IBA 01/2019 - 11/2011
16	CreatinineIBA 01/2022 - 09/2006
16	Glycoproteins (Glycoprotein)IBA 03/2015 - 07/2003
15	LDL CholesterolIBA 11/2020 - 05/2004
15	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2017 - 07/2005
14	omega-Chloroacetophenone (Mace)IBA 11/2020 - 09/2012
13	N(4)-oleylcytosine arabinosideIBA 01/2021 - 09/2014
13	Mineralocorticoid Receptor AntagonistsIBA 01/2020 - 08/2008
12	Pharmaceutical PreparationsIBA 01/2018 - 10/2004
12	Prasugrel Hydrochloride FDA Link 01/2018 - 04/2014
11	MetalsIBA 11/2020 - 01/2007
11	CholesterolIBA 01/2020 - 04/2014
11	TroponinIBA 01/2018 - 04/2005
10	oxidized low density lipoproteinIBA 07/2021 - 09/2009
10	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2019 - 11/2013
10	Dabigatran FDA Link 10/2019 - 11/2013
10	Angiotensin Receptor AntagonistsIBA 09/2017 - 02/2009
9	Anti-Arrhythmia AgentsIBA 01/2020 - 07/2013
9	Purinergic P2 Receptors (ADP Receptor)IBA 01/2019 - 08/2014
8	apixabanIBA 11/2019 - 11/2016
8	Insulin (Novolin)FDA Link 01/2018 - 08/2002
8	Heparin (Liquaemin)FDA LinkGeneric 06/2014 - 12/2005
7	HDL CholesterolIBA 01/2022 - 10/2008
7	Streptokinase FDA Link 01/2017 - 11/2003
7	Platelet Membrane Glycoprotein IIbIBA 12/2010 - 07/2003
6	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022 - 12/2005
6	Factor Xa InhibitorsIBA 01/2020 - 09/2016
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 08/2005
6	ORALIT (ORS)IBA 02/2014 - 09/2006
5	Amiodarone (Amiodarona)FDA LinkGeneric 01/2020 - 09/2009
5	Hypoglycemic Agents (Hypoglycemics)IBA 12/2019 - 03/2010
5	TicagrelorIBA 01/2019 - 12/2015
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2016 - 09/2006
5	Hemoglobins (Hemoglobin)IBA 01/2015 - 11/2008

Therapy/Procedure

221	Therapeutics 01/2022 - 08/2002
102	Percutaneous Coronary Intervention 01/2020 - 09/2005
51	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 08/2002
32	Length of Stay 01/2019 - 10/2002
29	Patient Readmission 01/2020 - 10/2005
28	Stents 11/2020 - 05/2006
25	Secondary Prevention 01/2022 - 05/2004
22	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2020 - 04/2005
17	Thrombolytic Therapy 01/2022 - 10/2007
14	Drug-Eluting Stents 11/2020 - 09/2005
14	Contraindications 10/2016 - 07/2005
12	Transcatheter Aortic Valve Replacement 01/2021 - 11/2013
5	Resuscitation 01/2020 - 09/2009
5	Surgical Instruments (Clip) 12/2017 - 12/2015
5	Cardiac Rehabilitation 11/2015 - 07/2005
5	Blood Transfusion (Blood Transfusions) 01/2015 - 10/2005
5	Erythrocyte Transfusion 02/2014 - 03/2005